CG Oncology makes up about 2.7% of Stempoint Capital LP’s portfolio, making the stock its 11th largest position. Stempoint Capital LP owned about 0.23% of CG Oncology at the end of the most recent quarter. Whittier Trust Co. of Nevada Inc. purchased a new position in CG Oncology during the 4th quarter worth $27,000. CG Oncology, Inc. has a 12 month low of $23.65 and a 12 month high of $77.00. Receive News & Ratings for CG Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CG Oncology and related companies with MarketBeat.com's FREE daily email newsletter.